Abstract
Keywords
Adalimumab (172)Aspirin (168)Bortezomib (170)Cefepime (180)Demeclocycline* (176)Domperidone* (174)Dopamine (166)Epinephrine (166)Factor V Inhibitor (169)Flucloxacillin* (171)Fluoxetine* (167)Glucocorticoids (178)Infliximab (175)Natalizumab (179)Norepinephrine (166)Phenylephrine (166)Quinidine* (171)Tetracyclines (173)Varenicline (177)Venlafaxine* (167)
Get full access to this article
View all access options for this article.